Cite
HARVARD Citation
Ranganathan, U. et al. (n.d.). PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design. Lupus science & medicine. pp. A100-A101. [Online].